TAIWAN · TWSE / TPEx
PEI
智擎 · 4162 · TPEx (OTC) · Biotech and medical
Share price, 2026-10-19NT$56.801 month +3.6% · 1 year -12.3%
Directors and supervisors hold48,480,46233.7% of shares issued
Of which pledged0.0%0
Major shareholders (10%+) hold48,452,46233.7% of shares issued
Revenue, 2026-09+13.1%year on year
Share price, last 12 months
Daily closes adjusted for cash and stock dividends, against the TAIEX index rebased to the same start. Prices from Yahoo Finance.
Directors, officers and major shareholders
Holdings reported for 2026-09. At election = shares held when the director was elected. Related parties = holdings of the person's spouse, minor children and nominees. One person with two roles is listed once.
| Person | Role | At election | Now | Of the company | Pledged | Related parties |
|---|---|---|---|---|---|---|
| 許璋瑤 | Chairman | — | 0 | — | — | — |
| 行政院國家發展基金管理會 | Director · Major shareholder (10%+) | 22,585,654 | 22,585,654 | 15.72% | — | — |
| 吳明賢 | Director (corporate representative) | — | 0 | — | — | — |
| 林宜輝 | Director (corporate representative) | — | 0 | — | — | — |
| 侯明鋒 | Director | — | 0 | — | — | — |
| 許文紅 | Director | — | 0 | — | — | — |
| 台灣東洋藥品工業股份有限公司 | Director · Major shareholder (10%+) | 25,866,808 | 25,866,808 | 18.00% | — | — |
| 吳瑞文 | Director (corporate representative) | — | 0 | — | — | — |
| 林建煌 | Independent director | — | 0 | — | — | — |
| 邱文達 | Independent director | — | 0 | — | — | — |
| 羅寶珠 | Independent director | 28,000 | 28,000 | 0.02% | — | — |
| 王宏仁 | President | — | 32,000 | 0.02% | — | — |
| 沈柏年 | Manager | — | 29,448 | 0.02% | — | — |
| 謝維駿 | Manager | — | 13,000 | 0.01% | — | — |
| 洪福天 | Manager | — | 5,000 | 0.00% | — | — |
| 曹妤? | Chief financial officer · Chief accountant · Other | — | 6,000 | 0.00% | — | — |